Clinical Trial

A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD

Name: A Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD — clinical trial record (NCT06941350)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Evaluate the safety and efficacy of NCR102 injection in the treatment of SR-aGVHD patients who have failed second-line therapy.

Trial Details

NCT Number	NCT06941350
Lead Sponsor	Nuwacell Biotechnologies Co., Ltd.
Conditions	Acute Graft-versus-Host Disease
Enrollment	24 participants
Start Date	2025-04-28
Primary Completion	2026-10-30 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-23